
### [MONDO:0015136](http://purl.obolibrary.org/obo/MONDO_0015136)
**Label:** immunodeficiency due to a complement cascade protein anomaly

**Subclasses:** [MONDO:0015699](http://purl.obolibrary.org/obo/MONDO_0015699) (immunodeficiency due to a classical component pathway complement deficiency), [MONDO:0016061](http://purl.obolibrary.org/obo/MONDO_0016061) (immunodeficiency with factor H anomaly), [MONDO:0012908](http://purl.obolibrary.org/obo/MONDO_0012908) (complement component 6 deficiency), [MONDO:0013417](http://purl.obolibrary.org/obo/MONDO_0013417) (complement component 3 deficiency), [MONDO:0007361](http://purl.obolibrary.org/obo/MONDO_0007361) (C1 inhibitor deficiency), [MONDO:0013419](http://purl.obolibrary.org/obo/MONDO_0013419) (complement component C1S deficiency), [MONDO:0018727](http://purl.obolibrary.org/obo/MONDO_0018727) (immunodeficiency due to a complement regulatory deficiency), [MONDO:0018726](http://purl.obolibrary.org/obo/MONDO_0018726) (immunodeficiency due to a complement cascade component deficiency), [MONDO:0012295](http://purl.obolibrary.org/obo/MONDO_0012295) (complement component 5 deficiency), [MONDO:0013343](http://purl.obolibrary.org/obo/MONDO_0013343) (C1Q deficiency), [MONDO:0013421](http://purl.obolibrary.org/obo/MONDO_0013421) (type II complement component 8 deficiency), [MONDO:0013487](http://purl.obolibrary.org/obo/MONDO_0013487) (recurrent Neisseria infections due to factor d deficiency), [MONDO:0013422](http://purl.obolibrary.org/obo/MONDO_0013422) (type i complement component 8 deficiency), [MONDO:0012594](http://purl.obolibrary.org/obo/MONDO_0012594) (complement factor i deficiency), [MONDO:0009005](http://purl.obolibrary.org/obo/MONDO_0009005) (complement component C1R/C1S deficiency), [MONDO:0009006](http://purl.obolibrary.org/obo/MONDO_0009006) (complement component 2 deficiency), [MONDO:0012412](http://purl.obolibrary.org/obo/MONDO_0012412) (complement component 7 deficiency), [MONDO:0012858](http://purl.obolibrary.org/obo/MONDO_0012858) (primary CD59 deficiency), [MONDO:0013467](http://purl.obolibrary.org/obo/MONDO_0013467) (immunodeficiency due to ficolin3 deficiency), [MONDO:0013445](http://purl.obolibrary.org/obo/MONDO_0013445) (complement component 9 deficiency), [MONDO:0013720](http://purl.obolibrary.org/obo/MONDO_0013720) (complement component 4b deficiency), [MONDO:0013423](http://purl.obolibrary.org/obo/MONDO_0013423) (immunodeficiency due to MASP-2 deficiency), [MONDO:0013721](http://purl.obolibrary.org/obo/MONDO_0013721) (complement component 4a deficiency), [MONDO:0010713](http://purl.obolibrary.org/obo/MONDO_0010713) (Properdin deficiency), [MONDO:0015700](http://purl.obolibrary.org/obo/MONDO_0015700) (immunodeficiency due to a late component of complement deficiency), 

**Corr. equiv. classes:** [Orphanet:169150](http://www.orpha.net/ORDO/Orphanet_169150), [Orphanet:280133](http://www.orpha.net/ORDO/Orphanet_280133), [Orphanet:331190](http://www.orpha.net/ORDO/Orphanet_331190), [OMIM:609536](http://purl.obolibrary.org/obo/OMIM_609536), [Orphanet:459345](http://www.orpha.net/ORDO/Orphanet_459345), [Orphanet:459348](http://www.orpha.net/ORDO/Orphanet_459348), [OMIM:613860](http://purl.obolibrary.org/obo/OMIM_613860), [OMIM:613783](http://purl.obolibrary.org/obo/OMIM_613783), [Orphanet:2966](http://www.orpha.net/ORDO/Orphanet_2966), [OMIM:614379](http://purl.obolibrary.org/obo/OMIM_614379), [OMIM:613789](http://purl.obolibrary.org/obo/OMIM_613789), [OMIM:613825](http://purl.obolibrary.org/obo/OMIM_613825), [Orphanet:200421](http://www.orpha.net/ORDO/Orphanet_200421), [OMIM:217000](http://purl.obolibrary.org/obo/OMIM_217000), [OMIM:614380](http://purl.obolibrary.org/obo/OMIM_614380), [OMIM:312060](http://purl.obolibrary.org/obo/OMIM_312060), [OMIM:613791](http://purl.obolibrary.org/obo/OMIM_613791), [OMIM:613790](http://purl.obolibrary.org/obo/OMIM_613790), [Orphanet:459353](http://www.orpha.net/ORDO/Orphanet_459353), [OMIM:120790](http://purl.obolibrary.org/obo/OMIM_120790), [OMIM:613652](http://purl.obolibrary.org/obo/OMIM_613652), [OMIM:612300](http://purl.obolibrary.org/obo/OMIM_612300), [Orphanet:200418](http://www.orpha.net/ORDO/Orphanet_200418), [OMIM:612446](http://purl.obolibrary.org/obo/OMIM_612446), [OMIM:610102](http://purl.obolibrary.org/obo/OMIM_610102), [Orphanet:169147](http://www.orpha.net/ORDO/Orphanet_169147), [OMIM:613779](http://purl.obolibrary.org/obo/OMIM_613779), [OMIM:610984](http://purl.obolibrary.org/obo/OMIM_610984), [Orphanet:169467](http://www.orpha.net/ORDO/Orphanet_169467), [OMIM:216950](http://purl.obolibrary.org/obo/OMIM_216950), [Orphanet:331187](http://www.orpha.net/ORDO/Orphanet_331187), [OMIM:613912](http://purl.obolibrary.org/obo/OMIM_613912), [Orphanet:169464](http://www.orpha.net/ORDO/Orphanet_169464), 

**Class expressions from DL-Learner:**

- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0001939](http://purl.obolibrary.org/obo/HP_0001939) (Abnormality of metabolism/homeostasis))) 67.88%
- [HP:0000007](http://purl.obolibrary.org/obo/HP_0000007) (Autosomal recessive inheritance) and [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) 62.66%
- [HP:0000005](http://purl.obolibrary.org/obo/HP_0000005) (Mode of inheritance) and [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) 60.99%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0009124](http://purl.obolibrary.org/obo/HP_0009124) (Abnormality of adipose tissue))) 60.01%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0003549](http://purl.obolibrary.org/obo/HP_0003549) (Abnormality of connective tissue))) 60.01%
- [HP:0005339](http://purl.obolibrary.org/obo/HP_0005339) (Abnormality of complement system) 60.00%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0100820](http://purl.obolibrary.org/obo/HP_0100820) (Glomerulopathy))) 59.04%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0040063](http://purl.obolibrary.org/obo/HP_0040063) (Decreased adipose tissue))) 59.04%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0025021](http://purl.obolibrary.org/obo/HP_0025021) (Abnormal erythrocyte sedimentation rate))) 59.04%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0011799](http://purl.obolibrary.org/obo/HP_0011799) (Abnormality of facial soft tissue))) 59.04%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0009019](http://purl.obolibrary.org/obo/HP_0009019) (Progressive loss of facial adipose tissue))) 59.04%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0008887](http://purl.obolibrary.org/obo/HP_0008887) (Adipose tissue loss))) 59.04%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0003565](http://purl.obolibrary.org/obo/HP_0003565) (Elevated erythrocyte sedimentation rate))) 59.04%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0003138](http://purl.obolibrary.org/obo/HP_0003138) (Increased blood urea nitrogen))) 59.04%
- [HP:0004431](http://purl.obolibrary.org/obo/HP_0004431) (Complement deficiency) and (not ([HP:0001937](http://purl.obolibrary.org/obo/HP_0001937) (Microangiopathic hemolytic anemia))) 59.04%


